Venture capital firm Andreessen Horowitz said on Friday it was working with Eli Lilly to launch a $500 million venture fund that will be fully funded by the U.S. drugmaker.

Sevier County has engaged Blue Zones, the global leader in longevity research and community well-being transformation, to launch Blue Zones Ignite in the ...

Last year, Thrive Global teamed up with OpenAI to create Thrive AI Health, an AI-powered health coach trained on the ...

Our Rescue, a global non-governmental organization dedicated to combating sex trafficking and child exploitation is launching its #JoinTheFighttm campaign in support of National Human Trafficking ...

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

If innovative cancer therapies were the top launches to watch in 2024, this year’s high-profile biopharma debuts is slated to ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth ...

A $20 million Lilly Endowment grant aims to make Gary and ... The funding will launch NWI Thrive, a multi-faceted project that will include new trails, trail improvements, educational campaigns ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...